↓ Skip to main content

Michigan Publishing

Influenza Vaccination as Secondary Prevention for Cardiovascular Disease

Overview of attention for article published in Circulation, September 2006
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
6 news outlets
blogs
1 blog
policy
2 policy sources
twitter
4 X users
patent
1 patent

Citations

dimensions_citation
100 Dimensions

Readers on

mendeley
86 Mendeley
Title
Influenza Vaccination as Secondary Prevention for Cardiovascular Disease
Published in
Circulation, September 2006
DOI 10.1161/circulationaha.106.178242
Pubmed ID
Authors

Matthew M Davis, Kathryn Taubert, Andrea L Benin, David W Brown, George A Mensah, Larry M Baddour, Sandra Dunbar, Harlan M Krumholz

Abstract

Evidence from cohort studies and a randomized clinical trial indicates that annual vaccination against seasonal influenza prevents cardiovascular morbidity and all-cause mortality in patients with cardiovascular conditions. The American Heart Association and American College of Cardiology recommend influenza immunization with inactivated vaccine (administered intramuscularly) as part of comprehensive secondary prevention in persons with coronary and other atherosclerotic vascular disease (Class I, Level B). Immunization with live, attenuated vaccine (administered intranasally) is not currently recommended [corrected] for persons with cardiovascular conditions. It is important to note that influenza vaccination coverage levels overall and in this population remain well below national goals and are marked by disparities across different age and ethnic groups. One of the barriers to vaccination for patients with cardiovascular disease is that cardiology practices frequently do not stock and administer influenza vaccine. Healthcare providers who treat individuals with cardiovascular disease can help improve influenza vaccination coverage rates by providing and strongly recommending vaccination to their patients before and throughout the influenza season.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Spain 2 2%
United Kingdom 1 1%
Japan 1 1%
Unknown 80 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 17%
Student > Master 11 13%
Other 9 10%
Student > Ph. D. Student 9 10%
Student > Bachelor 7 8%
Other 23 27%
Unknown 12 14%
Readers by discipline Count As %
Medicine and Dentistry 46 53%
Nursing and Health Professions 7 8%
Agricultural and Biological Sciences 3 3%
Psychology 2 2%
Biochemistry, Genetics and Molecular Biology 2 2%
Other 6 7%
Unknown 20 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 63. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2022.
All research outputs
#679,937
of 25,374,647 outputs
Outputs from Circulation
#1,774
of 21,095 outputs
Outputs of similar age
#1,000
of 87,723 outputs
Outputs of similar age from Circulation
#4
of 141 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 21,095 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.4. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 87,723 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.